P-REALITY X: prolonging metastatic breast cancer survival by adding palbociclib to an aromatase inhibitor
Summary
Our partnered journal Future Oncology recently published a plain language summary of publication describing a real-world database analysis exploring how adding palbociclib to an aromatase inhibitor could prolong the life of people with metastatic HR+/HER2– breast cancer in routine clinical practice.
View the full article